Columbia Capital’s VanEck Pharmaceutical ETF PPH Stock Holding History

Columbia Capital’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-52,383	Closed	-$3.25M	–	59
2014 Q2	$3.25M	Buy	52,383 +357	+0.7%	+$21.2K	2.56%	6
2014 Q1	$2.99M	Buy	52,026 +174	+0.3%	+$9.84K	2.15%	5
2013 Q4	$2.75M	Buy	51,852 +220	+0.4%	+$11.1K	2.43%	7
2013 Q3	$2.48M	Buy	51,632 +301	+0.6%	+$14.3K	2.23%	9
2013 Q2	$2.33M	Buy	+51,331	New	+$2.37M	2.41%	14

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

MIM

Macroview Investment Management Bethesda, Maryland $162M AUM 22.52% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Columbia Capital's PPH Position: Q3 2014 in Review

Columbia Capital sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2014, closing a stake of 52,383 shares — an estimated $3.25M sold.

Columbia Capital first reported a position in PPH in Q2 2013 and held it in 5 quarters. The position peaked at $3.25M in Q2 2014. 49 funds tracked by Wall St. Rank hold PPH as of Q3 2014.

Columbia Capital reported no remaining VanEck Pharmaceutical ETF position as of Q3 2014 after selling out during the quarter.
Columbia Capital sold 52,383 VanEck Pharmaceutical ETF shares in Q3 2014, an estimated $3.25M.
Columbia Capital first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and held it in 5 quarters.
Columbia Capital's VanEck Pharmaceutical ETF position peaked at $3.25M in Q2 2014.
49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2014.

Based on Columbia Capital's 13F filing for Q3 2014, filed 16 Oct 2014.